BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38008826)

  • 21. ETV4 is a theranostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent manner.
    Xu L; Hu H; Zheng LS; Wang MY; Mei Y; Peng LX; Qiang YY; Li CZ; Meng DF; Wang MD; Liu ZJ; Li XJ; Huang BJ; Qian CN
    Cancer Lett; 2020 Jul; 482():74-89. PubMed ID: 32305558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
    Deng H; Gong X; Ji G; Li C; Cheng S
    Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR.
    Luo L; Wei D; Pan Y; Wang QX; Feng JX; Yu B; Kang T; Luo J; Yang J; Gao S
    Cancer Commun (Lond); 2023 Jul; 43(7):808-833. PubMed ID: 37378422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LTB4R Promotes the Occurrence and Progression of Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating the AKT/mTOR Signaling Pathway.
    Zhang X; Wu H; Yan X; Ma J; Chen Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hierarchical network of hypoxia-inducible factor and SMAD proteins governs procollagen lysyl hydroxylase 2 induction by hypoxia and transforming growth factor β1.
    Rosell-García T; Palomo-Álvarez O; Rodríguez-Pascual F
    J Biol Chem; 2019 Sep; 294(39):14308-14318. PubMed ID: 31391253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway.
    Zhou X; Dong S; Zhou Y; He Z; Zhang Z; Liao L; Zou B; Zheng X; Peng K; Duan X
    Mol Carcinog; 2024 May; 63(5):951-961. PubMed ID: 38362840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NHERF4 hijacks Mas-mediated PLC/AKT signaling to suppress the invasive potential of clear cell renal cell carcinoma cells.
    Yang Y; Liang J; Zhao C; Chen Y; Gu S; Yang X; Liu H; Qin Q; Wang H; Yang Z; Cao X; Feng D; He J
    Cancer Lett; 2021 Oct; 519():130-140. PubMed ID: 34216689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion.
    Xu Y; Zhang L; Wei Y; Zhang X; Xu R; Han M; Huang B; Chen A; Li W; Zhang Q; Li G; Wang J; Zhao P; Li X
    Oncotarget; 2017 Apr; 8(14):23401-23413. PubMed ID: 28423580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.
    Noda T; Yamamoto H; Takemasa I; Yamada D; Uemura M; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Liver Int; 2012 Jan; 32(1):110-8. PubMed ID: 22098155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
    Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
    Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
    Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
    Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
    Li DY; Lin FF; Li GP; Zeng FC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma.
    Xu WH; Xu Y; Wang J; Tian X; Wu J; Wan FN; Wang HK; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2019 Aug; 11(16):6503-6521. PubMed ID: 31446433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway.
    He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P
    Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling.
    Feng Q; Cheng M; Jin J; Zhang S; Bai Y; Xu J
    Acta Histochem; 2022 Apr; 124(3):151874. PubMed ID: 35299128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.
    Zhou L; Yang H
    PLoS One; 2011; 6(9):e23936. PubMed ID: 21949687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
    Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
    BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of PLOD2 induced osimertinib resistance in non-small cell lung cancer HCC827 cells].
    Kang XH; Wang K; Wang Y; Zhao HK; Zhang J; Zhao KL; Miao ZH; Xu ZY; Cao F; Gong YB
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):210-215. PubMed ID: 32252199
    [No Abstract]   [Full Text] [Related]  

  • 39. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.
    Eisinger-Mathason TS; Zhang M; Qiu Q; Skuli N; Nakazawa MS; Karakasheva T; Mucaj V; Shay JE; Stangenberg L; Sadri N; Puré E; Yoon SS; Kirsch DG; Simon MC
    Cancer Discov; 2013 Oct; 3(10):1190-205. PubMed ID: 23906982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.